VRSN options put-call ratio spikes ahead of earnings

VeriSign reports earnings today. The put-call ratio has jumped to 0.63, more than 2.3 standard deviations above its 20-day mean of 0.23, the sharpest options skew toward downside protection in months.

The move in the options market is the most striking data point right now. The PCR sat below 0.20 for most of September and early October. It then tripled in the space of a few sessions, reaching 0.63 on October 21. The 52-week high is 1.30, so the current reading is elevated but not extreme. What matters is the speed of the shift.

Retail attention surges in parallel

Wikipedia views and ORTEX stock-page traffic are running 3.06 standard deviations above their combined 90-day average, per ORTEX Alt Data. That is a measure of retail attention, not a revenue or earnings indicator, but the timing is notable. Interest in the stock has spiked on the same timeline as the options positioning change.

Cost to borrow and short interest

The cost to borrow reached 0.51% on October 19, up sharply from 0.08% the prior week, before retreating to 0.28% on October 21. The borrow market remains extremely loose: availability stands at 8,413% of short interest, meaning shares to borrow are plentiful relative to current short positioning. Short interest is 2.4% of the free float, up 44% over the past month in absolute share terms but still low relative to float. The borrow market tells a story of cost volatility, not a tight squeeze setup.

The bull and bear framing into the print

Wedbush raised its price target to $351 on October 19, maintaining its Outperform rating. The mean analyst target is $326, against a current price of $307.25. VeriSign's bull case rests on its .com and .net registry pricing power, with a 7% .com price increase starting November 1 and a .net increase planned for March 2027. Revenue forecasts of $1.76 billion for 2026 and $1.94 billion for 2027 sit alongside margins near 68%.

The bear case centres on the single-product concentration risk and the possibility of regulatory intervention capping future price increases. Negative book value, driven by debt-funded buybacks, is also a concern.

CEO D. James Bidzos sold shares on October 13 and October 20, all under a pre-arranged 10b5-1 plan. Plan-driven sales carry far less signal than discretionary transactions.

Data summary

• Put-call ratio: 0.63, z-score of 2.33 above the 20-day mean of 0.23
• Cost to borrow: 0.28% as of October 21, up from 0.08% on October 12
• Borrow availability: 8,413% of short interest, extremely loose
• Short interest: 2.4% of free float, up 44% over one month
• Retail attention: 3.06 standard deviations above 90-day average
• Wedbush target: $351, raised October 19; mean analyst target $326
• Earnings: reported after close October 22